Survival curves at a median follow-up of 86 months, and MRD evaluation. (A) PFS of all patients (7-year PFS, 55% [95% CI, 41-67]); (B) OS of all patients (7-year OS, 63% [95% CI, 49-74]); (C) Duration of response for the 52 responding patients (7-year duration of response, 59% [95% CI, 44-71]); (D) PFS (7-year PFS, 65% vs 40%; P = .14) and (E) OS (7-year OS, 65% vs 45%; P = .16) based on the MRD results at the end of the treatment (blue curve, positive; red curve, negative).